课题基金 / 基金详情

BETA ADRENERGIC BLOCKADE IN PATIENTS WITH CONGESTIVE HEART FAILURE

BETA ADRENERGIC BLOCKADE IN PATIENTS WITH CONGESTIVE HEART FAILURE
充血性心力衰竭患者的β肾上腺素能阻断剂
批准号:
6245213
负责人:
MICHAEL R. BRISTOW
金额:
$2.65万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-02-14 至 1997-11-30

项目摘要

项目成果

MICHAEL R. BRISTOW的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This is a NIH R01 supported investigation of the beta adrenergic receptor signal transduction system and it's response to chronic beta adrenergic receptor blockade in patients with heart failure. This study, set up as a collaborative effort with the gcrc at the university of utah, utilizes in vivo assessment of cardiac circulatory and renal physiology and in vitro measurements of cardiac gene expression before and following 6 months of beta blocker therapy. Preliminary data have been presented at the american college of cardiology and the american heart association annual scientific sessions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BETA-BLOCKER EFFECT ON REMODELING AND GENE EXPRESSION
  • 批准号:
    7719425
  • 项目类别:
  • 资助金额:
    $0.12万
  • 财政年份:
    2008
  • 负责人:
    MICHAEL R. BRISTOW
  • 依托单位:
BETA-BLOCKER EFFECT ON REMODELING AND GENE EXPRESSION
  • 批准号:
    7604375
  • 项目类别:
  • 资助金额:
    $1.01万
  • 财政年份:
    2007
  • 负责人:
    MICHAEL R. BRISTOW
  • 依托单位:
BETA-BLOCKER EFFECT ON REMODELING AND GENE EXPRESSION
  • 批准号:
    7377772
  • 项目类别:
  • 资助金额:
    $2.69万
  • 财政年份:
    2006
  • 负责人:
    MICHAEL R. BRISTOW
  • 依托单位:
BETA-BLOCKER EFFECT ON REMODELING AND GENE EXPRESSION
  • 批准号:
    7200533
  • 项目类别:
  • 资助金额:
    $2.06万
  • 财政年份:
    2005
  • 负责人:
    MICHAEL R. BRISTOW
  • 依托单位: